ProCE Banner Activity

Understanding  Management of R/R MM: Current Treatment Strategies for Sequencing Available Agents


Download these slides from a live symposium for an overview of current considerations for treatment options for patients with relapsed/refractory multiple myeloma.

Released: December 18, 2023

Begin Activity



Philippe Moreau

Philippe Moreau, MD

Professor of Clinical Hematology
University Hospital of Nantes
Nantes, France

Provided by

Provided by Clinical Care Options, LLC in partnership with the International Myeloma Foundation.

ProCE Banner


Supported by educational grants from Karyopharm Therapeutics, Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme.

Karyopharm Therapeutics

Regeneron Pharmaceuticals, Inc

Sanofi Genzyme


International Myeloma Foundation

ProCE Banner